Relmada Therapeutics
RLMD | NASDAQ
$3.61
-$0.60 (-14.25%)
At close: Nov 16, 2026, 4:00 PM ET
$3.61
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Relmada Therapeutics Statistics
Key statistics explainedMarket Data
$405.9M
$203.78M
0.45
1.6M
112.44M
238.75%
90.09%
NASDAQ
US75955J4022
Price Performance
16.4%
-24.3%
-43.1%
-25.3%
-9.1%
415.7%
-15.8%
16.5%
-8.6%
-0.7%
18.7%
Valuation
-4.88
N/A
-0.05
0.12
N/A
12.50
2.10
-7.83
-7.00
-7.85
N/A
-3.93
-3.14
-3.93
-20.5%
-12.8%
-14.3%
Financial Health
$202.12M
$0
$202.12M
$205.3M
26.37
26.37
0.00
-0.00
-0.00
N/A
0.00
19.82
3
Margins & Profitability
0.0%
0.0%
0.0%
0.0%
N/A
N/A
0.0%
-11.8%
Returns
-32.0%
-37.3%
-34.4%
-34.4%
-32.0%
Historical Growth (CAGR)
N/A
N/A
N/A
59.1%
40.5%
3.3%
1.4%
22.1%
-15.0%
Analyst Forecasts
Buy
2
-13.1%
N/A
Mar 18, 2027
-$0.16
-40.7%
N/A
N/A
Fair Value Estimates
N/A
N/A
N/A
N/A
$12.00
232.4%
Cash Flow
$-51.86M
$-51.86M
$-57.95M
-$0.46
-$0.46
0.0%
Income Statement
$0
$0
$-67.9M
$-64.93M
$-65.7M
-$0.74
N/A
$-3.86M
17
Add to Watchlist
Select watchlists to add or remove RLMD